Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-006668

President and CEO gave up 3,675 shares (to pay taxes)

  • President and CEO acquired 10,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2020-02-03 Option exercise +10,800 932,578 D: show line 1 in the form
Walker Neal President and CEO 2020-02-03 Shares withheld for taxes −3,675 $1.28 $4,704 928,903 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2020-02-03 Option exercise · Restricted Stock Units −10,800 21,600 D: show line 3 in the form
Loading xslF345X03/doc4.xml…